<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Abbreviated New Drug Applications Submissions-Refuse-To-Receive Standards: Questions and Answers; Draft Guidance for Industry; Availability</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Abbreviated New Drug Applications Submissions-Refuse-To-Receive Standards: Questions and Answers; Draft Guidance for Industry; Availability</h1>
    <p class="timestamp">Published: 2017-10-03 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled "ANDA Submissions--Refuse-to-Receive Standards: Questions and Answers." This draft guidance is intended to assist applicants preparing to submit abbreviated new drug applications (ANDAs) and certain prior approval supplements (PASs) to ANDAs. This guidance provides answers to questions we have received from applicants regarding the guidance for industry, "ANDA Submissions--Re...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2017-21187</p>
    <p><strong>Publication Date:</strong> 2017-10-03</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2017/10/03/2017-21187/abbreviated-new-drug-applications-submissions-refuse-to-receive-standards-questions-and-answers">https://www.federalregister.gov/documents/2017/10/03/2017-21187/abbreviated-new-drug-applications-submissions-refuse-to-receive-standards-questions-and-answers</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2017-21187</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
